FINWIRES · TerminalLIVE
FINWIRES

Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell

By

Parabilis Medicines (PBLS) reported a Q2 loss Thursday $2.32 per diluted share, compared a loss of $22.28 a year earlier.

Analysts from FactSet expected a loss of $0.36.

Collaboration revenue for the quarter ended June 30 was $148,000. The company did not report any revenue a year ago.

As of June 30, the company has cash, cash equivalents and marketable securities of $1.1 billion, which it said are expected to fund its operations into 2030.

Shares of the company were up over 6% in Thursday's premarket activity.

Price: $39.99, Change: $+2.58, Percent Change: +6.90%

Related Articles

Wire

GBM Resources Confirms Continuation of Prospective Gold Host at Queensland Project; Shares Down 5%

GBM Resources (ASX:GBM) confirmed the continuation of the prospective Milled Matrix Breccia host horizon at least 700 meters south of the 309 mineral resource at the Stella prospect, expanding the exploration footprint at the Twin Hills project in Queensland, according to a Thursday filing with the Australian bourse.The company intersected gold mineralization during step-out drilling, with assays returning 8 meters at 1.31 grams per tonne grade of gold from 126 meters, the filing said.Further assays are expected to be released in the next two weeks, per the filing.Shares fell 5% in midday trade Thursday.

ASX:GBM
Wire

Pan American Silver Q2 Adjusted Earnings, Revenue Rise; Shares Drop After Hours

Pan American Silver (PAAS) reported Q2 adjusted earnings late Wednesday of $0.73 per basic share, up from $0.43 a year earlier.Analysts polled by FactSet expected $0.88.Revenue for the quarter ended June 30 rose to $1.12 billion from $812 million a year earlier.Three analysts expected $1.15 billion.The company raised its quarterly dividend to $0.184 a share from $0.18, payable around Sept. 4 to stockholders of record Aug. 24.Pan American Silver shares fell 5.1% in after-hours trading.

$PAAS
Wire

Stantec Q2 Adjusted Earnings, Revenue Rise

Stantec (STN) reported Q2 adjusted earnings late Wednesday of 1.61 Canadian dollars ($1.15) per diluted share, up from CA$1.36 a year earlier.Analysts surveyed by FactSet expected CA$1.58.Net revenue in the three months ended June 30 rose to CA$1.78 billion from CA$1.6 billion a year earlier.Analysts projected CA$1.79 billion.Stantec shares rose 1.3% in after-hours trading.

$STN